Influence of indomethacin-mastic combinations on dissolution absorption and gastrointestinal mucosal damage in rats

International Journal of Pharmaceutics

Volumn 158, Issue 2, 1997, Pages 137-145

  Gabr, K E ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Anti ulcerogenicity; Bioavailability; Dissolution; Indomethacin; Mastic; Particle size analysis; X ray diffraction

Indexed keywords

INDOMETACIN; LACTOSE; MASTIC; POLYSORBATE 80; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; DIGESTIVE SYSTEM INJURY; DISSOLUTION; DRUG ABSORPTION; DRUG MIXTURE; DRUG RELEASE; DRUG SOLUBILITY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PARTICLE SIZE; PRIORITY JOURNAL; RAT; ULCEROGENESIS; X RAY DIFFRACTION;

EID: 0031452412     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00226-3     Document Type: Article

References (21)

1. Abdel-Aleem H.M. Formulation and evaluation of mastic in antacid preparations. Alex. J. Pharm. Sci. 10:1996;65-68.
2. Al-Said M.S., Ageel A.H., Parmar N.S., Tarek M. Evaluation of mastic, a crude drug obtained from Pistacia lentiscus for gastric and doudenal anti-ulcer activity. J. Ethnopharmacol. 15:1986;271-278.
3. BPC, 1973. British Pharmaceutical Codex, The Pharmaceutical Press, London, p. 284.
4. Chowdary K.P., Suresh-Babu K.V. Dissolution, bioavailability and ulcerogenic studies on solid dispersions of indomethacin in water soluble cellulose polymers. Drug Dev. Ind. Pharm. 20:1994;799-813.
5. Flower, R.J., Moncada, S., Vane, J.R., 1985. In: Goodman, A.G., Goodman, L.S., Rall, T.W., Murad, F. (Eds.), Goodman and Gelman's, The Pharmacological Basis of Therapeutics, 7th ed. MacMillan, New York, pp. 695-697.
6. Foda A.M., Said S. Effect of complexation of indomethacin and calcium glycerophosphate on its bioavailability, ulcerogenicity and anti-inflamatory activity in rats. Pharm. Ind. 53:1991;94-97.
7. Gaballah A.M., Zeid S.E., Ibrahim T.M., Gameil N.M., Abdel-Hamed A. Comparative study of the effects of natural honey and antacid (aluminium phosphate) on the anti-inflamatory and ulcerogenic activity of indomethacin. Mansoura Med. J. 21:1991;37-52.
8. Georgarakis M., Groning R., Henzler P. Microencasulation of potassium chloride with mastic. Pharmazie. 42:1987;455-456.
9. Gibaldi, M., Perrier, D., 1982. Pharmacokinetics, 2nd ed. Marcel Dekker, New York.
10. Hassan, M.Z., 1989. Selected Herbo-Mineral Remedies, Islamic Organization for Medical Sciences, Kuwait, pp. 45 and 148.
11. Hilton J.E., Summers M.P. Effect of indomethacin microcapsukles on intestinal ulceration in the rats. Drug Dev. Ind. Pharm. 13:1987;1611-1624.
12. Hucker H.B., Zacchei A.G., Cox S.V., Brodie D.A., Cantwell N.H.R. Studies on the absorption, distribution and exceration of indomethacin in various species. Pharmac. Exp. Therap. 153:1966;237-249.
13. Liverside G.G., Dent J., Eickhoff W.M. Influence of indomethacin amphoteric gel on gastric ulcerogenicity and absorption of indomethacin in rats. Pharm. Res. 6:1989;44-48.
14. Martin, A., Bustamante, P., Chun, A.H.C., 1993. Physical Pharmacy: Physicochemical Principles on the Pharmaceutical Sciences, 4th ed. Lea and Fabiger, Philadelphia, London.
15. Martindale, 1982. The Extra Pharmacopoeia, 28th ed. The Pharmaceutical Press, London, p. 315.
16. Meshali M.M., Nightingale C.H. Effect of alpha tocopherol (Vit. E) defficiency on intestinal transport of passively absorbed drugs. J. Pharm. Sci. 65:1976;344-349.
17. Nakamura J., Takada S., Ohtsuka N., Heya T., Yamamoto A., Kimura T., Sezaki H. An assesment of indomethacin-induced gastrointestinsal mucosal damage in-vivo: enhacement of urinary recovery after oral administration of phenolsulphonephthalein in rats. J. Pharm. Pharmacol. 35:1983;369-372.
18. Panagopoulou A., Georgarakis M. Effect of compression and diluent on drug release from mastic matrix tablets. A stastistical analysis. Drug Dev. Ind. Pharm. 16:1990;637-649.
19. Singla A.K., Mediratta D.K., Pathak K. Bioavailability of indomethacin fron zinc-indomethacin complex. Int. J. Pharm. 60:1990;27-33.
20. Tammara V.K., Narurkar M.M., Crider A.M., Khan M.A. Synthesis and evaluation of morpholinoalkyl ester prodrugs of indomethacin and naproxin. Pharm. Res. 10:1993;1191-1199.
21. Yuasa H., Ozeki T., Kanaya Y., Oishi K., Oyake T. Application of the solid dispersion method to controlled release of medicine. I. Controlled release of water soluble medicine by using solid dispersion. Chem. Pharm. Bull. 39:1991;465-467.